Inactive Instrument

News OHR Pharmaceutical Inc Nasdaq

Equities

US67778H3093

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

NeuBase Therapeutics Announces Receipt of Notice from Nasdaq	Apr. 05	AQ
Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading	Mar. 26	MT
US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings	Mar. 26	MT
Top Premarket Decliners	Mar. 26	MT
North American Morning Briefing : Tech in Focus on -2-	Mar. 25	DJ
North American Morning Briefing : Investors -2-	Mar. 18	DJ
North American Morning Briefing : Stock Futures -2-	Mar. 11	DJ
North American Morning Briefing : Traders Await -2-	Feb. 26	DJ
NeuBase Therapeutics, Inc. Announces CEO Changes	Jan. 17	CI
North American Morning Briefing : S&P 500 Eyes Record High as Rate Cut Hopes Underpin Sentiment	Dec. 19	DJ
NeuBase Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
NeuBase Therapeutics : Material Event - Form 8-K	23-10-20	PU
Neubase Therapeutics, Inc. Announces Franklyn G. Prendergast Board of Directors Passed Away	23-10-20	CI
Thinking about buying stock in Navios Maritime Holdings, Biodexa Pharmaceuticals, Iovance Biotherapeutics, Neubase Therapeutics, or Iris Energy?	23-09-18	PR
Thinking about buying stock in Immunitybio, Aurora Cannabis, Elutia, Canopy Growth, or Neubase Therapeutics?	23-09-11	PR
NeuBase Therapeutics Issues Statement Regarding Filing By Shareholder	23-09-08	AQ
Top Premarket Decliners	23-09-07	MT
Top Midday Gainers	23-09-06	MT
NEUBASE THERAPEUTICS SHARES UP 40% AFTER SYMETRYX CORPORATION AC…	23-09-06	RE
SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE	23-09-06	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News OHR Pharmaceutical Inc Nasdaq

Equities

US67778H3093

Summary

Filters